Clinical Trial Update: Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide

View source ↗

Summary

This clinical trial update notes the withdrawal of a study investigating molecular signatures of relapse in tissue from patients with small cell lung cancer tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: University of Southern California | Conditions: Small Cell Lung Cancer | Status: WITHDRAWN